TB-500 in India | Prime Peptide

Q: What is TB-500?

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"TB-500 is a name used for synthetic research materials associated with thymosin beta-4 biology. Because the label is not always used consistently, product-specific sequence, identity, purity, and analytical documentation are important when interpreting research results."}]}]}

Q: Is TB-500 the same as thymosin beta-4?

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Not necessarily. Thymosin beta-4 is a defined endogenous 43-amino-acid peptide. TB-500 is a commercial or research-material designation that may be used for different thymosin beta-4-related preparations. Evidence from thymosin beta-4 studies should only be applied to a TB-500 material when molecular identity and formulation equivalence are established."}]}]}

Q: Which pathways are studied in the thymosin beta-4 context?

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Published thymosin beta-4 research examines actin sequestration and cytoskeletal remodeling, cell migration, extracellular-matrix responses, endothelial migration, angiogenic signaling, and tissue-repair processes. These pathways are literature context and are not direct claims about an analytically unspecified TB-500 material."}]}]}

Q: How strong is the evidence associated with TB-500?

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"There is a substantial preclinical literature for full-length thymosin beta-4, but much less formulation-specific evidence for materials sold under the name TB-500. The distinction between the defined biological peptide and a commercial preparation must be preserved, and broad clinical conclusions should not be inferred from cell or animal studies."}]}]}

PRODUCT OVERVIEW

What is TB-500?

TB-500 is a commercial research name used for thymosin-beta-4-related peptide materials. Because suppliers may use this name for different molecular forms, the exact sequence, formula, and molecular weight must be confirmed from the received batch COA before experimental use.

This page connects TB-500 to actin dynamics, cell migration, endothelial signaling, glossary context, FAQs, and source records while clearly distinguishing the sold research material from native thymosin beta-4.

Purity≥99%

Molecular WeightVerify exact molecular identity on batch COA

SequenceAdd product metafield

StorageStore refrigerated at 2–8°C

FormLyophilized powder

Research UseFor in-vitro laboratory research only

Research mechanism Product-specific pathway illustration

RESEARCH AREAS

TB-500 Potential Use Cases

Product-specific research applications associated with Prime Peptide TB-500.

Actin cytoskeleton dynamics research

Cell-migration assays

Endothelial migration and angiogenic-signaling models

Tissue-repair signaling research

Thymosin beta-4 comparative studies

Batch identity and peptide-characterization work

KEY BENEFITS

TB-500 Research Highlights

Key research-oriented characteristics connected to Prime Peptide TB-500.

Connects the product to actin and migration research pathways
Clearly distinguishes TB-500 material from native thymosin beta-4
Supports comparative cell-migration and repair-signaling studies
Uses batch-specific identity verification instead of unsupported molecular claims

SPECIFICATIONS

TB-500 Molecular Data

Molecular specifications for Prime Peptide TB-500
Molecular Formula	Verify exact molecular identity on batch COA
Molecular Weight	Verify exact molecular identity on batch COA
Purity	≥99%
Appearance	White to off-white lyophilized powder
Solubility	Solubility depends on the exact molecular form, concentration, pH, and solvent system. Follow the batch COA and validated laboratory protocol.
Storage	Store refrigerated at 2–8°C
Research Use	For in-vitro laboratory research only

3D Structure · Representative Model

BIOLOGICAL & MOLECULAR TARGETS

TB-500 Research Targets

Actin cytoskeleton dynamics

Actin dynamics

Cytoskeletal regulatory pathway

Thymosin beta-4 research describes binding to monomeric actin and regulation of actin polymerization, cytoskeletal organization, and cell motility. This pathway is included as literature context for TB-500-related research and does not establish that every material sold as TB-500 is identical to full-length thymosin beta-4.

View reference ↗

Cell migration and tissue-repair signaling

Migration/repair

Cellular repair process

Full-length thymosin beta-4 has been studied in cellular migration, extracellular-matrix remodeling, and wound-repair models. These findings provide cautious pathway context only and should not be transferred automatically to an unspecified TB-500 preparation.

View reference ↗

Endothelial migration and angiogenic signaling

Endothelial migration

Vascular cellular pathway

Thymosin beta-4 has been investigated in endothelial-cell migration and angiogenesis-related experimental systems, including cytoskeletal and PI3K/Akt/eNOS-associated responses. This entry describes the evidence base for thymosin beta-4 rather than proving formulation equivalence with TB-500.

View reference ↗

SCIENTIFIC SOURCES

TB-500 Citations & References

Thymosin beta4 stimulates directional migration of human umbilical vein endothelial cells

FASEB Journal 1997

Primary endothelial-cell study reporting directional migration responses to thymosin beta-4. This is evidence for full-length thymosin beta-4, not automatic proof of equivalence for products labeled TB-500.

Read publication →

Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta

Experimental Cell Research 2007

Cellular study examining thymosin beta-4-associated epithelial migration and matrix-remodeling responses. It provides mechanistic context for the full-length peptide.

Read publication →

Thymosin beta4 promotes endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway

Journal of Cardiovascular Pharmacology 2009

Preclinical study of endothelial progenitor-cell migration and PI3K/Akt/eNOS-associated signaling in response to thymosin beta-4.

Read publication →

TERMINOLOGY

TB-500 Glossary

TB-500 — A marketplace and research-material name associated with a synthetic thymosin beta-4-related peptide; exact identity and equivalence should be verified from analytical documentation.

TB-500 is commonly described as a synthetic peptide related to thymosin beta-4. However, the name is used inconsistently across suppliers, and published studies on endogenous or recombinant full-length thymosin beta-4 should not automatically be treated as direct evidence for every TB-500 material. Sequence, purity, and identity should be established through product-specific analytical documentation.

Also known as: TB500, thymosin beta-4-related research peptide

Thymosin beta-4 — An endogenous 43-amino-acid actin-binding peptide involved in cytoskeletal organization, cell migration, and tissue-repair research.

Thymosin beta-4 is a naturally occurring 43-amino-acid peptide that binds globular actin and has been studied in cell migration, endothelial biology, inflammation, and tissue-repair models. It must be distinguished from products labeled TB-500 unless analytical evidence establishes the precise molecular identity.

Also known as: Tβ4, TMSB4X peptide Source ↗

Actin sequestration — Reversible binding of monomeric actin that regulates the pool available for filament assembly.

Actin sequestration controls the availability of globular actin for polymerization into filaments. Thymosin beta-4 is a major intracellular actin-sequestering peptide and is therefore studied in cytoskeletal remodeling and motility.

Also known as: G-actin sequestration, actin monomer binding Source ↗

Cell migration — The coordinated movement of cells through changes in cytoskeleton, adhesion, and extracellular-matrix interactions.

Cell migration is a multistep process involving actin remodeling, adhesion turnover, signaling, and interaction with extracellular matrix. It is a common endpoint in thymosin beta-4 tissue-repair and endothelial research.

Also known as: cell motility, cellular migration Source ↗

COMMON RESEARCH QUESTIONS

TB-500 FAQ

What is TB-500?

TB-500 is a name used for synthetic research materials associated with thymosin beta-4 biology. Because the label is not always used consistently, product-specific sequence, identity, purity, and analytical documentation are important when interpreting research results.

Is TB-500 the same as thymosin beta-4?

Not necessarily. Thymosin beta-4 is a defined endogenous 43-amino-acid peptide. TB-500 is a commercial or research-material designation that may be used for different thymosin beta-4-related preparations. Evidence from thymosin beta-4 studies should only be applied to a TB-500 material when molecular identity and formulation equivalence are established.

Which pathways are studied in the thymosin beta-4 context?

Published thymosin beta-4 research examines actin sequestration and cytoskeletal remodeling, cell migration, extracellular-matrix responses, endothelial migration, angiogenic signaling, and tissue-repair processes. These pathways are literature context and are not direct claims about an analytically unspecified TB-500 material.

How strong is the evidence associated with TB-500?

There is a substantial preclinical literature for full-length thymosin beta-4, but much less formulation-specific evidence for materials sold under the name TB-500. The distinction between the defined biological peptide and a commercial preparation must be preserved, and broad clinical conclusions should not be inferred from cell or animal studies.